Bendamustine HCL Injection

• Type: Anticancer (chemotherapy) drug

• Drug Class: Alkylating agent with some antimetabolite properties

• Form: Intravenous injection or infusion

How It Works

• Bendamustine damages cancer cell DNA by forming cross-links between DNA strands.

• This prevents cancer cells from dividing and leads to cell death.

• It also acts partly like an antimetabolite, interfering with the building blocks of DNA and RNA.

• These combined effects make it effective against rapidly growing cancer cells.

Common Uses

• Chronic Lymphocytic Leukemia (CLL)

• Non-Hodgkin’s Lymphoma (NHL) — particularly slow-growing types

• Multiple Myeloma (sometimes used)

• Other blood cancers as determined by oncologists

Advantages

• Effective against cancers that are resistant to other treatments

• Often has a better side effect profile compared to some older chemotherapy drugs

• Can be used alone or in combination with other cancer medicines

Possible Side Effects

• Bone marrow suppression (low white blood cells, red blood cells, platelets → risk of infection, anemia, bleeding)

• Nausea, vomiting

• Fatigue and weakness

• Fever or infections

• Rash or skin reactions

• Hair thinning (less common than with many chemotherapies)

• Rare: secondary cancers with long-term use

Precautions

• Requires regular blood tests to monitor blood counts and organ function

• Patients should avoid live vaccines during treatment

• Use caution in people with liver or kidney problems

• Effective contraception is recommended, as it may harm an unborn baby

• Must be administered under supervision of a trained oncologist or healthcare professional